An open-label, dose-escalation and multi-center study to evaluate the safety and pharmacokinetics of SAR650984 in patients with relapsed/refractory multiple myeloma - Regional Cancer Care Associates LLC

Clinical Trials

An open-label, dose-escalation and multi-center study to evaluate the safety and pharmacokinetics of SAR650984 in patients with relapsed/refractory multiple myeloma

Type of Cancer
Multiple Myeloma
Locations
Hackensack
Sponsor
Sanofi Aventis
Protocol Number
TED14154
Cancer Diagnosis
To Learn More Call
201-510-0910